U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H20ClN5O3
Molecular Weight 377.825
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DASOLAMPANEL

SMILES

[H][C@@]12CC[C@@H](C[C@]1([H])C[C@H](NC2)C(O)=O)OC3=C(C4=NN=NN4)C(Cl)=CC=C3

InChI

InChIKey=LAKQPSQCICNZII-NOHGZBONSA-N
InChI=1S/C17H20ClN5O3/c18-12-2-1-3-14(15(12)16-20-22-23-21-16)26-11-5-4-9-8-19-13(17(24)25)7-10(9)6-11/h1-3,9-11,13,19H,4-8H2,(H,24,25)(H,20,21,22,23)/t9-,10+,11-,13-/m0/s1

HIDE SMILES / InChI

Molecular Formula C17H20ClN5O3
Molecular Weight 377.825
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Dasolampanel (NGX-426) is an orally available competitive antagonist of the AMPA and kainate receptors. The dug originated at Eli Lilly and Horizon Pharma and was developed for the treatment of migraine and neuropathic pain. Dasalompanel was reduced capsaicin-induced pain and hyperalgesia in human volunteers but failed to achieve positive results in phase 2 clinical trials in patients with pain due to osteoarthritis of the knee and diabetic peripheral neuropathic pain.

Approval Year

Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 20:15:00 GMT 2023
Edited
by admin
on Fri Dec 15 20:15:00 GMT 2023
Record UNII
1P85D6BE9K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DASOLAMPANEL
INN   USAN  
USAN   INN  
Official Name English
dasolampanel [INN]
Common Name English
3-ISOQUINOLINECARBOXYLIC ACID, 6-(3-CHLORO-2-(2H-TETRAZOL-5-YL)PHENOXY)DECAHYDRO-, (3S,4AS,6S,8AR)-
Common Name English
(3S,4AS,6S,8AR)-6-(3-CHLORO-2-(1H-TETRAZOL-5-YL)PHENOXY)-DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID
Common Name English
DASOLAMPANEL [USAN]
Common Name English
Code System Code Type Description
WIKIPEDIA
DASOLAMPANEL
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
PUBCHEM
51049972
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
USAN
XX-76
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
SMS_ID
300000037044
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
INN
9436
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
NCI_THESAURUS
C166510
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
CAS
503294-13-1
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
FDA UNII
1P85D6BE9K
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
EPA CompTox
DTXSID401032046
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
ChEMBL
CHEMBL2103869
Created by admin on Fri Dec 15 20:15:00 GMT 2023 , Edited by admin on Fri Dec 15 20:15:00 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY